UBS Asset Management Americas Inc. Reduces Position in Express Scripts Holding (ESRX)

UBS Asset Management Americas Inc. decreased its stake in shares of Express Scripts Holding (NASDAQ:ESRX) by 1.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,756,335 shares of the company’s stock after selling 45,876 shares during the quarter. UBS Asset Management Americas Inc.’s holdings in Express Scripts were worth $205,733,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the stock. National Asset Management Inc. lifted its position in Express Scripts by 1.5% during the second quarter. National Asset Management Inc. now owns 7,939 shares of the company’s stock valued at $510,000 after purchasing an additional 115 shares during the last quarter. James Investment Research Inc. lifted its position in Express Scripts by 2.2% during the fourth quarter. James Investment Research Inc. now owns 30,241 shares of the company’s stock valued at $2,257,000 after purchasing an additional 656 shares during the last quarter. First National Bank of Omaha lifted its position in Express Scripts by 7.4% during the fourth quarter. First National Bank of Omaha now owns 11,060 shares of the company’s stock valued at $825,000 after purchasing an additional 765 shares during the last quarter. Palladium Partners LLC lifted its position in Express Scripts by 4.1% during the fourth quarter. Palladium Partners LLC now owns 19,666 shares of the company’s stock valued at $1,468,000 after purchasing an additional 772 shares during the last quarter. Finally, Alpha Windward LLC lifted its position in Express Scripts by 35.9% during the fourth quarter. Alpha Windward LLC now owns 2,981 shares of the company’s stock valued at $223,000 after purchasing an additional 787 shares during the last quarter. Hedge funds and other institutional investors own 87.46% of the company’s stock.

Several equities analysts have commented on ESRX shares. SunTrust Banks reiterated a “buy” rating and set a $95.00 price objective on shares of Express Scripts in a research report on Friday, January 12th. Robert W. Baird upgraded shares of Express Scripts from a “neutral” rating to an “outperform” rating and increased their price objective for the company from $72.00 to $81.00 in a research report on Friday, December 15th. Raymond James Financial reiterated a “sell” rating on shares of Express Scripts in a research report on Friday, December 15th. Needham & Company LLC reiterated a “hold” rating on shares of Express Scripts in a research report on Thursday, December 21st. Finally, Mizuho set a $67.00 price objective on shares of Express Scripts and gave the company a “hold” rating in a research report on Tuesday, October 24th. Five analysts have rated the stock with a sell rating, eight have given a hold rating, nine have given a buy rating and one has given a strong buy rating to the stock. Express Scripts has an average rating of “Hold” and a consensus target price of $78.93.

In related news, VP Glen D. Stettin sold 3,448 shares of the firm’s stock in a transaction dated Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total value of $262,048.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, VP Christine Houston sold 10,104 shares of the firm’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $70.08, for a total transaction of $708,088.32. Following the completion of the transaction, the vice president now directly owns 87,400 shares in the company, valued at approximately $6,124,992. The disclosure for this sale can be found here. In the last three months, insiders sold 17,001 shares of company stock worth $1,249,505. Insiders own 0.68% of the company’s stock.

Shares of Express Scripts Holding (NASDAQ:ESRX) opened at $75.23 on Friday. Express Scripts Holding has a 12 month low of $55.80 and a 12 month high of $83.49. The firm has a market cap of $42,610.00, a price-to-earnings ratio of 12.50, a PEG ratio of 0.81 and a beta of 0.93. The company has a quick ratio of 0.61, a current ratio of 0.73 and a debt-to-equity ratio of 0.86.

Express Scripts declared that its board has approved a stock buyback program on Monday, December 18th that authorizes the company to repurchase 45,000,000 outstanding shares. This repurchase authorization authorizes the company to reacquire shares of its stock through open market purchases. Shares repurchase programs are often a sign that the company’s board of directors believes its stock is undervalued.

ILLEGAL ACTIVITY WARNING: “UBS Asset Management Americas Inc. Reduces Position in Express Scripts Holding (ESRX)” was first published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this report on another site, it was stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this report can be viewed at https://stocknewstimes.com/2018/02/18/ubs-asset-management-americas-inc-reduces-position-in-express-scripts-holding-esrx.html.

Express Scripts Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply